References
- Mannaerts B, Shoam Z, Schoot D. et al. Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489) in gonadotropin-deficient volunteers. Fertil Steril 1998; 69(Suppl 1)15S–20S
- Bergh C, Howies CM, Borg K, et al. Recombinant human follicle stimulating hormone (r-hFSH; Gonal F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997; 12: 2133–9
- Devroey P, Tournaye H, Van Steirtghem A, et al. The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in vitro fertilization. Hum Reprod 1998; 13: 565–6
- Keene JL, Matzuc MM, Otani T, et al. Expression of biologically active human follitropin in Chinese hamster ovary cells. J Biol Chem 1989; 246: 4769–75
- Van Wezenbeek P, Draaier J, Van Meel F, Okijve W. Recombinant follicle-stimulating hormone. I. Construction, selection and characterization of a cell line. From Clone to Clinic, Developments in Biotherapy, DJ Crommelin, H Shellekens. Kluwer Academic Publishers, Dordrecht 1990; 245–51
- Out HJ, Mannaerts BMJL, Driessen SGAJ, et al. Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Hum Reprod Update 1996; 2: 162–71
- Out HJ, Mannaerts BMJL, Driessen SGAJ, et al. A prospective, randomized, assessor-blind, multi-center study comparing recombinant and urinary follicle-stimulating hormone (Puregon vs Metrodin) in in vitro fertilization. Hum Reprod 1995; 10: 2534–40
- Jacob S, Drudy L, Conroy R, et al. Outcome from consecutive in vitro fertilization/ intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone. Hum Reprod 1998; 13: 1783–7
- Acosta AA, Jones GS, Garcia JE, et al. Correlation of human menopausal gonadotropin/human chorionic gonadotropin stimulation and oocyte quality in an in vitro fertilization program. Fertil Steril 1984; 41: 196–201
- Daya S, Gunby J. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod 1999; 14: 2207–15
- Franco JG, Jr, Baruffi RLR, Mauri AL, et al. Ovarian synchrony factor: a new ultrasound parameter in the prognosis of follicular rupture. Hum Reprod 1994; 9: 1250–2
- Eldar-Geva T, Lowe JM, MacLachlan V, et al. Different influence of incongruent follicular development on in vitro fertilization-embryo transfer and gamete intrafallopian transfer pregnancy rates. Fertil Steril 1998; 70: 1039–43
- Paulson RJ, Sauer MV, Lobo RA. Factors affecting embryo implantation after human in vitro fertilization: a hypothesis. Am J Obstet Gynecol 1990; 163: 2020–3
- Plancha CE, Albertini DF. Hormonal regulation of meiotic maturation in the hamster oocyte involves a cytoskeleton-mediated process. Bio Reprod 1994; 51: 852–64
- Plachot M. Assisted reproduction. Viability of preimplantation embryos. Ballières Clin Obstet Gynaecol 1992; 6: 327–38